PLX Investors Have Opportunity to Join Protalix BioTherapeutics, Inc. Fraud Investigation with the Schall Law Firm
Protalix BioTherapeutics(US:PLX) Businesswire·2025-11-01 08:31法律调查 - Protalix BioTherapeutics公司面临Schall Law律师事务所发起的欺诈调查 [1] - 调查为PLX投资者提供了参与机会 [1]